🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Hydroxychloroquine retinal toxicity affects a significant number of patient...
Status
Recruiting
Location
Local de Saúde São José
Start Date
2024-08-01
Trial ID
NCT06839443
Treatments Being Tested
In this randomized clinical trial, 100 eyes with nonproliferative diabetic ...
Status
Unknown
Location
Multiple Locations
Start Date
2020-09-01
Trial ID
NCT04511715
Imaging of retinal morphological changes with time secondary to laser treat...
Status
Completed
Location
Dept. of Opthalmology, Medical University of Vienna
Start Date
2007-10
Trial ID
NCT00682240
The purpose of this study is to identify alterations of the blood-retinal b...
Status
Completed
Location
AIBILI
Start Date
2010-11
Trial ID
NCT01220804
The purpose of this study is to evaluate the pharmacokinetics, safety and p...
Status
Completed
Location
Retina Associates of Cleveland
Start Date
2006-01
Trial ID
NCT00306904
Treatments Being Tested
This study intends to take the critical pathological mechanism of diabetic ...
Status
Not Yet Recruiting
Location
Hospital of Chengdu University of Traditional Chinese Medicine
Start Date
2026-01-01
Trial ID
NCT06813274
Treatments Being Tested
The purpose of the study is to determine whether concentrations of FOV2304 ...
Status
Completed
Location
Center 1115
Start Date
2011-05
Trial ID
NCT01319487
Treatments Being Tested
Diabetic retinopathy (DR) is a leading cause of vision loss in working-age ...
Status
Active Not Recruiting
Location
Oregon Health & Science University
Start Date
2017-08-30
Trial ID
NCT03922932
The PROTECT2 pilot study is a single cohort prospective study to gather pil...
Status
Unknown
Location
Dean McGee Eye Institute
Start Date
2016-03-17
Trial ID
NCT03094819
Treatments Being Tested
The medical records of 393 eyes of 326 patients with severe proliferative d...
Status
Completed
Location
Makoto Inoue
Start Date
2007-04
Trial ID
NCT02464800
Treatments Being Tested